2018-10-13 05:00:00| Fool.com Headlines
The company's plan to restructure itself isn't sparking investor optimism.
2018-10-12 22:34:00| Fool.com Headlines
Find out how earnings hurt some of these stocks.
2018-10-12 15:00:00| Fool.com Headlines
Adamas' steady march lower continued in September. Here's why.
2018-10-12 00:15:00| Fool.com Headlines
Investors were not impressed with the biotech's R&D day.
2018-10-11 21:58:00| Fool.com Headlines
Investors are excited about data for its hepatitis B drug.